Treatment of heart failure in non-human animal mammals by aldosterone antagonist

Details for Australian Patent Application No. 2008267227 (hide)

Owner CEVA SANTE ANIMALE

Inventors Guyonnet, Jerome; Bernay, Florence; Ovaert, Patricia

Agent Griffith Hack

Pub. Number AU-A-2008267227

PCT Pub. Number WO2009/000843

Priority 61/048,419 28.04.08 US; 0704584 26.06.07 FR

Filing date 25 June 2008

Wipo publication date 31 December 2008

International Classifications

A61K 31/585 (2006.01)

A61K 31/401 (2006.01) - Proline

A61K 31/50 (2006.01) - Pyridazines

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/000843 Priority application(s): WO2009/000843

18 February 2010 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name CEVA SANTE ANIMALE, Application No. 2008267227, under INID (54) correct the title to read Treatment of heart failure in non-human animal mammals by an aldosterone antagonist

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008267237-Combination formulations comprising darunavir and etravirine

2008267220-Refillable multi-dose container applicable to a machine for preparing beverages